Congress Presentations

Stay informed about the latest scientific and medical research from Axsome.

Filter

Sort

SLEEP 2026

Baltimore, MD | June 14 - 17, 2026

Narcolepsy

Symptom Burden and Quality of Life in Patients With Narcolepsy Who Experience Residual Cataplexy: Subgroup Analysis From the CRESCENDO Survey

View / Download

AXS-12 | Narcolepsy

Cognitive and Functional Outcomes From the Phase 3 Open-Label Extension and Randomized-Withdrawal ENCORE Study of AXS-12 in Narcolepsy with Cataplexy

View / Download

Sunosi® | Excessive Daytime Sleepiness

Solriamfetol for Excessive Daytime Sleepiness in Narcolepsy and OSA: Post-Hoc Multi-Dimensional Composite Endpoint Analysis of Phase 3 Trials

View / Download

This site contains scientific information about investigational compounds and/or information about products and/or uses that have not been approved by the US Food and Drug Administration. The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.

AXSOME, AUVELITY, SUNOSI, SYMBRAVO and their logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.